All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Galectin-3 as an independent prognostic factor after heart transplantation

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F22%3A00082650" target="_blank" >RIV/00023001:_____/22:00082650 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11120/22:43922791

  • Result on the web

    <a href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/ctr.14592" target="_blank" >https://onlinelibrary.wiley.com/doi/epdf/10.1111/ctr.14592</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/ctr.14592" target="_blank" >10.1111/ctr.14592</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Galectin-3 as an independent prognostic factor after heart transplantation

  • Original language description

    Background Galectin-3 (GAL3) is linked to the prognosis of patients with heart failure and after heart transplantation (HTx). We assessed the prognostic role of GAL3 in a long-term follow-up after HTx. Methods HTx patients (N = 121) were evaluated in a single-center, noninterventional, prospective, observational study. The median follow-up was 96 months (2942 days, interquartile range (IQR) 2408-3264 days), and 40 patients died. GAL3 was measured before HTx, +10 days after HTx, and during the first posttransplant year. Survival analysis (all-cause mortality) was performed with adjustments for clinical and laboratory variables. Results The median pretransplant GAL3 level was 18.0 mu g/L (IQR 14.0-25.9), and higher values were associated with older age, worse kidney function, left ventricular assist device use before HTx, a higher IMPACT score, and mortality. Increased pretransplant GAL3 predicted shorter survival time (HR 2.05, 95% CI 1.09-3.85, p &lt; .05). Similar prognostic power had GAL3 on the 10th posttransplant day (HR 2.03, 95% CI 1.08-3.82, p &lt; .05). GAL3 was an independent predictor of death after adjustment for clinical variables (age, infection, diabetes, smoking, IMPACT score, and troponin). Conclusions GAL3 was significantly associated with all-cause mortality after adjusting for clinical and laboratory variables and may serve as an additional prognostic biomarker.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30213 - Transplantation

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2022

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Clinical transplantation

  • ISSN

    0902-0063

  • e-ISSN

    1399-0012

  • Volume of the periodical

    36

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    9

  • Pages from-to

    "Art. no e14592"

  • UT code for WoS article

    000749666300001

  • EID of the result in the Scopus database

    2-s2.0-85123718888